Patterns in the Emergence of Epidemic Meningococcal Disease

作者: Jay D. Wenger , Bradley A. Perkins

DOI: 10.1128/9781555816940.CH8

关键词:

摘要: This chapter reviews several recent surges in disease activity caused by the three main meningococcal serogroups (A, C and B) 1990s discusses current future strategies for prevention. The mortality rate of untreated meningitis has not been recorded recently but was reported to be as high 75% preantibiotic era. precise reason distinct seasonality is unclear may related drying effect on mucous membranes, seasonal transmission respiratory viruses, or other factors. More importantly, nasopharyngeal mucosa intercurrent tract infections contribute invasiveness, carriage, both. Complete immunization coverage with polysaccharide vaccine critical halt epidemic disease. In early 1990s, public health personnel Oregon noticed increasing rates general population surprisingly focal outbreaks. epidemiologic pattern similar endemic patterns most respects, including seasonality, sex distribution, rates. A constant low level a variety and, within each serogroup, individual strains. history outbreaks due A, B, suggests that strains will continue arise cause major crises both developing developed countries.

参考文章(38)
Claire V. Broome, The carrier state: Neisseria meningitidis. Journal of Antimicrobial Chemotherapy. ,vol. 18, pp. 25- 34 ,(1986) , 10.1093/JAC/18.SUPPLEMENT_A.25
Lapeyssonnie L, CEREBROSPINAL MENINGITIS IN AFRICA Bulletin of The World Health Organization. ,vol. 28, pp. 1- 114 ,(1963)
C T Sacchi, L L Pessoa, S R Ramos, L G Milagres, M C Camargo, N T Hidalgo, C E Melles, D A Caugant, C E Frasch, Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. Journal of Clinical Microbiology. ,vol. 30, pp. 1734- 1738 ,(1992) , 10.1128/JCM.30.7.1734-1738.1992
M. Dionne, J. Drapeau, M. Douville-Fradet, G. De Serres, N. Boulianne, P. De Wals, Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada. Bulletin of The World Health Organization. ,vol. 74, pp. 407- 411 ,(1996)
F E Ashton, J A Ryan, A Borczyk, D A Caugant, L Mancino, D Huang, Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. Journal of Clinical Microbiology. ,vol. 29, pp. 2489- 2493 ,(1991) , 10.1128/JCM.29.11.2489-2493.1991
Stephen Eaton Hume, Mass Voluntary Immunization Campaigns for Meningococcal Disease in Canada: Media Hysteria JAMA: The Journal of the American Medical Association. ,vol. 267, pp. 1833- 1838 ,(1992) , 10.1001/JAMA.1992.03480130153046
Marc Fischer, Bradley A. Perkins, Neisseria meningitidis serogroup B: Emergence of the ET-5 complex Seminars in Pediatric Infectious Diseases. ,vol. 8, pp. 50- 56 ,(1997) , 10.1016/S1045-1870(97)80009-X
Patrick S Moore, John Hierholzer, Wallis DeWitt, Koulienga Gouant, Dezoumbe Djoré, Theo Lippeveld, Brian Plikaytis, Claire V Broome, Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA. ,vol. 264, pp. 1271- 1275 ,(1990) , 10.1001/JAMA.1990.03450100061026
Simon Flexner, THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS Journal of Experimental Medicine. ,vol. 17, pp. 553- 576 ,(1913) , 10.1084/JEM.17.5.553